DocStoX is a free AI-powered research platform for Indian equity markets, covering 5,700+ NSE & BSE stocks with prices, fundamentals, 326 financial ratios, shareholding, FII/DII flows, F&O, IPOs, a visual screener and AI stock scoring.

Yes. DocStoX has a free tier covering stock research, the screener, FII/DII data and educational guides, plus a free MCP API tier (50 tool calls/day) for AI assistants. A Pro plan adds higher limits and advanced features.

What data does DocStoX cover?

Every NSE & BSE listed stock (5,700+ instruments): EOD and intraday prices, income statement / balance sheet / cash flow, 326 ratios, quarterly shareholding, promoter pledge, mutual-fund holdings, FII/DII flows, F&O and option-chain data, analyst forecasts, IPOs, corporate actions and news.

Can AI assistants like ChatGPT or Claude use DocStoX data?

Yes. DocStoX runs a public Model Context Protocol (MCP) server at https://mcp.docstox.com/mcp with 94 tools, so Claude, ChatGPT, Cursor and other MCP clients can pull Indian market data directly. Setup and a free key are at https://docstox.com/mcp.

Negative impactCorporate Action

Aarti Pharmalabs Limited — Resignation

NSE 1 hr ago·28 Oct 2026, 3:39 pm

Aarti Pharmalabs

Aarti Pharmalabs Limited has informed the Exchange regarding Resignation of Shri Piyush Lakhani as Chief Financial Officer of the company He will be relievedfrom the services of the Company with effect from the close of business hours on October 30, 2026.

Affected stocks

Bearish1 stock

Aarti Pharmalabs

AARTIPHARM Bearish

₹881.95

Bull / bear label is derived from the article's AI sentiment — indicative, not advice. Prices may be delayed.

Key takeaways

Concerns Aarti Pharmalabs (AARTIPHARM).
Category: Corporate Action.
AI reads the tone as negative (potentially bearish) for the stock.

Why it matters

A routine update for Aarti Pharmalabs. The tone is negative — watch for downside reaction. Use the price and stock snapshot to gauge how the market is responding.

Summary & analysis by DocStoX. Full story at NSE.